NO20002483D0 - Nye 19-nor-steroider substituert i posisjon 11B, fremgangsmÕte for fremstilling av slike samt mellomprodukter, deres anvendelse som medisiner, og farmasøytiske preparater inneholdende disse - Google Patents

Nye 19-nor-steroider substituert i posisjon 11B, fremgangsmÕte for fremstilling av slike samt mellomprodukter, deres anvendelse som medisiner, og farmasøytiske preparater inneholdende disse

Info

Publication number
NO20002483D0
NO20002483D0 NO20002483A NO20002483A NO20002483D0 NO 20002483 D0 NO20002483 D0 NO 20002483D0 NO 20002483 A NO20002483 A NO 20002483A NO 20002483 A NO20002483 A NO 20002483A NO 20002483 D0 NO20002483 D0 NO 20002483D0
Authority
NO
Norway
Prior art keywords
medicines
intermediates
novel
processes
preparation
Prior art date
Application number
NO20002483A
Other languages
English (en)
Other versions
NO20002483L (no
Inventor
Francois Nique
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO20002483D0 publication Critical patent/NO20002483D0/no
Publication of NO20002483L publication Critical patent/NO20002483L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20002483A 1997-11-17 2000-05-12 Nye 19-norsteroider substituert i posisjon 11B, fremstillingsfremgangsmÕte og intermediater, anvendelse som medisiner og farmasøytiske preparater som inneholder dem NO20002483L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714357A FR2771096B1 (fr) 1997-11-17 1997-11-17 Nouveaux 19-nor steroides, substitues en position 11beta, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
PCT/FR1998/002437 WO1999025725A1 (fr) 1997-11-17 1998-11-16 NOUVEAUX 19-NOR STEROÏDES SUBSTITUES EN POSITION 11β, PROCEDE ET INTERMEDIAIRES DE PREPARATION, APPLICATION COMME MEDICAMENTS ET COMPOSITIONS PHARMACEUTIQUES LES RENFERMANT

Publications (2)

Publication Number Publication Date
NO20002483D0 true NO20002483D0 (no) 2000-05-12
NO20002483L NO20002483L (no) 2000-07-17

Family

ID=9513422

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002483A NO20002483L (no) 1997-11-17 2000-05-12 Nye 19-norsteroider substituert i posisjon 11B, fremstillingsfremgangsmÕte og intermediater, anvendelse som medisiner og farmasøytiske preparater som inneholder dem

Country Status (25)

Country Link
US (2) US6479476B1 (no)
EP (1) EP1032584B1 (no)
JP (1) JP4476480B2 (no)
KR (1) KR20010032127A (no)
CN (1) CN1286694A (no)
AR (1) AR016012A1 (no)
AT (1) ATE232542T1 (no)
AU (1) AU754846B2 (no)
BR (1) BR9814201A (no)
CA (1) CA2309242A1 (no)
CZ (1) CZ20001799A3 (no)
DE (1) DE69811393T2 (no)
EA (1) EA003133B1 (no)
ES (1) ES2192341T3 (no)
FR (1) FR2771096B1 (no)
HR (1) HRP20000315A2 (no)
HU (1) HUP0100210A3 (no)
ID (1) ID24236A (no)
IL (1) IL136148A0 (no)
NO (1) NO20002483L (no)
PL (1) PL340381A1 (no)
SK (1) SK7052000A3 (no)
TR (1) TR200001405T2 (no)
WO (1) WO1999025725A1 (no)
ZA (1) ZA9810358B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2780060B1 (fr) * 1998-06-23 2000-08-04 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
DE19929715A1 (de) 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
FR2826004B1 (fr) 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
FR2854403B1 (fr) * 2003-04-29 2008-07-11 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes
US10400006B2 (en) * 2014-11-26 2019-09-03 The Regents Of The University Of California Estrogen receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978657A (en) * 1981-01-09 1990-12-18 Roussel Uclaf Novel 11β-substituted-19-nor-steroids
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
DE69811393D1 (de) 2003-03-20
FR2771096A1 (fr) 1999-05-21
ZA9810358B (en) 1999-11-12
EA003133B1 (ru) 2003-02-27
EP1032584A1 (fr) 2000-09-06
ID24236A (id) 2000-07-13
DE69811393T2 (de) 2003-08-28
PL340381A1 (en) 2001-01-29
SK7052000A3 (en) 2000-12-11
AU1242699A (en) 1999-06-07
JP4476480B2 (ja) 2010-06-09
HUP0100210A1 (hu) 2001-08-28
US20030073675A1 (en) 2003-04-17
KR20010032127A (ko) 2001-04-16
US6693090B2 (en) 2004-02-17
JP2001523687A (ja) 2001-11-27
TR200001405T2 (tr) 2001-05-21
FR2771096B1 (fr) 2000-08-11
CA2309242A1 (fr) 1999-05-27
AU754846B2 (en) 2002-11-28
NO20002483L (no) 2000-07-17
EA200000530A1 (ru) 2000-10-30
US6479476B1 (en) 2002-11-12
CZ20001799A3 (cs) 2001-11-14
AR016012A1 (es) 2001-05-30
EP1032584B1 (fr) 2003-02-12
WO1999025725A1 (fr) 1999-05-27
BR9814201A (pt) 2000-09-26
HUP0100210A3 (en) 2001-12-28
IL136148A0 (en) 2001-05-20
ATE232542T1 (de) 2003-02-15
HRP20000315A2 (en) 2000-10-31
ES2192341T3 (es) 2003-10-01
CN1286694A (zh) 2001-03-07

Similar Documents

Publication Publication Date Title
DK0920441T3 (da) 7alfa-(epsilon-aminoalkyl)-estratriener, fremgangsmåde til deres fremstilling, farmaceutiske præparater, som indeholder disse 7-alfa-(epsilon-aminoalkyl)-estratriener, samt deres anvendelse til fremstilling af lægemidler
NO20010013D0 (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
NO20042694L (no) 17 alfa-alkyl-17 beta-oksy-ostratriener og mellomprodukter for fremstilling av disse, anvendelse av 17 alfa-alkyl-17 beta-oksy-ostratrienene til fremstilling av legemidler samt farmasoytiske preparater
DK1098874T3 (da) Benzocycloheptener, fremgangsmåder til deres fremstilling, farmaceutiske præparater, som indeholder disse, samt deres anvendelse til fremstilling af lægemidler
NO991130D0 (no) Modifiserte aminosyrer, farmas°ytiske preparater som inneholder disse forbindelsene og fremgangsmÕter for fremstilling derav
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
DK0918059T3 (da) Susbstituerede imidazolidinderivater, deres fremstilling og anvendelse samt farmaceutiske præparater indeholdende disse derivater
NO20003496L (no) Nye aromatiske amider, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medisiner
NO994620D0 (no) Nye 2-(iminometyl)amino-fenyl-derivater, fremstilling, anvendelse som medisiner og farmasöytiske blandinger inneholdende disse
NO308287B1 (no) Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse
NO984309D0 (no) Nye imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse
NO307510B1 (no) Bicykliske aromatiske forbindelser, deres anvendelse og farmasøytiske og kosmetiske preparater derav
NO942910L (no) Nye baccatin-III- og 10-desacetyl-baccatin-III-derivater, deres fremstillinger, samt farmasöytiske preparater inneholdende derivatene
DK1187847T3 (da) Streptograminderivater, deres fremstilling samt præparater indeholdende disse derivater
DK1015421T3 (da) Nye phenylamidinderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler
NO20003661D0 (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
NO872778D0 (no) Nye 4-pyridonderivater, fremgangsmaate til deres fremstilling og farmasoeytiske preparater som inneholder disse.
NO20002483D0 (no) Nye 19-nor-steroider substituert i posisjon 11B, fremgangsmÕte for fremstilling av slike samt mellomprodukter, deres anvendelse som medisiner, og farmasøytiske preparater inneholdende disse
NO984476L (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
DK409786A (da) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-oner, fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler, pharmaceutiske praeparater og mellemprodukter
DK0858459T3 (da) Nye sure pyrazolforbindelser, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler, deres nye anvendelse og farmaceutiske præparater med indhold deraf
DK0913396T3 (da) Sulfonamid-substituerede benzopyranderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske præparater indeholdende disse forbindelser
NO984475L (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO993125L (no) Steroider substituert i posisjon 11, fremgangsmåte for fremstilling av disse, deres anvendelse som medisiner samt farmasöytiske preparater inneholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application